NSG Bio has announced the opening of its latest facility, NSG BioSuites, at the new Geneo development in Singapore Science Park. This marks the company’s fourth and largest site in Singapore, aimed at providing innovative and accessible solutions for the biotech community. The facility offers small to large private lab suites, designed to support both biology and chemistry labs, and is BSL-2 certified.
NSG BioSuites is equipped with shared resources such as a Tissue Culture Room, Bacteria Room, and access to over 150 shared pieces of equipment at Geneo alone, contributing to a total of 450 across all NSG Bio sites. This infrastructure is intended to lower the barriers for biotech companies of all sizes to access world-class laboratory facilities.
Beyond the physical infrastructure, NSG BioSuites aims to foster a collaborative ecosystem. Companies based at the facility can benefit from strategic partnerships, mentorship opportunities, and community-driven initiatives. Daphne Teo, Chairwoman of the Board and Founder of NSG Bio, stated, “Our mission has always been to make high-quality biotech space more accessible, whilst empowering companies with the tools, networks, and collaborations needed to thrive.”
The launch of NSG BioSuites at Geneo underscores NSG Bio’s commitment to advancing Singapore’s life sciences ecosystem by combining private suites with shared facilities and a robust support network. This initiative is set to drive innovation and accessibility in the biotech sector, offering companies a platform to spearhead research and breakthroughs.
